Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Bioengineering (Basel, Switzerland)|January 8, 2025
Analysis of Inertial Measurement Unit Data for an AI-Based Physical Function Assessment System Using In-Clinic-like MovementsNobuji Kouno, Satoshi Takahashi, Ken Takasawa, et al.
Briefings in Bioinformatics|July 5, 2022
Application of non-negative matrix factorization in oncology: one approach for establishing precision medicineRyuji Hamamoto, Ken Takasawa, Hidenori Machino, et al.
Journal of Medical Systems|September 12, 2024
Comparison of Vision Transformers and Convolutional Neural Networks in Medical Image Analysis: A Systematic ReviewSatoshi Takahashi, Yusuke Sakaguchi, Nobuji Kouno, et al.
BMC Medical Informatics and Decision Making|February 18, 2025
A series of natural language processing for predicting tumor response evaluation and survival curve from electronic health recordsToshiki Takeuchi, Hidehito Horinouchi, Ken Takasawa, et al.
Experimental Hematology & Oncology|November 1, 2022
Introducing AI to the molecular tumor board: one direction toward the establishment of precision medicine using large-scale cancer clinical and biological informationRyuji Hamamoto, Takafumi Koyama, Nobuji Kouno, et al.
Cancers|December 1, 2020
Application of Artificial Intelligence Technology in Oncology: Towards the Establishment of Precision MedicineRyuji Hamamoto, Kruthi Suvarna, Masayoshi Yamada, et al.
Experimental & Molecular Medicine|March 3, 2024
Advances in cancer DNA methylation analysis with methPLIER: use of non-negative matrix factorization and knowledge-based constraints to enhance biological interpretabilityKen Takasawa, Ken Asada, Syuzo Kaneko, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2025
Prediction recurrence in stage I epidermal growth factor receptor-mutated non-small cell lung cancer using multi-modal dataAkiko Tateishi, Hidehito Horinouchi, Nobuji Kouno, et al.
Molecular Cancer|September 1, 2024
Multi-omics and clustering analyses reveal the mechanisms underlying unmet needs for patients with lung adenocarcinoma and identify potential therapeutic targetsKen Asada, Syuzo Kaneko, Ken Takasawa, et al.
Molecular Cancer|June 11, 2024
Mechanism of ERBB2 gene overexpression by the formation of super-enhancer with genomic structural abnormalities in lung adenocarcinoma without clinically actionable genetic alterationsSyuzo Kaneko, Ken Takasawa, Ken Asada, et al.
Pageof 3